Belgium vs Malaysia: Number of isolates tested for ceftriaxone
Belgium
159
in 2020
Malaysia
132
in 2020
Belgium rank
20th
Malaysia rank
23rd
Number of isolates tested for ceftriaxone over time
- Belgium
- Malaysia
How they compare
Belgium currently reports 159 against 132 in Malaysia, a difference of 27.
That makes Belgium's figure about 1.2 times Malaysia's.
The two have swapped places 2 times across 5 shared years of data; in 2009 it was Belgium ahead.
Belgium ranks 20th and Malaysia ranks 23rd of 52 countries.
Belgium has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belgium | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 110 | 17 | 93 | Belgium |
| 2010s | 129.33 | 129 | 0.3333 | Belgium |
| 2020s | 159 | 132 | 27 | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Belgium or Malaysia?
- Belgium, at 159 against 132 in Malaysia as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between Belgium and Malaysia?
- 27, with Belgium ahead.
- How many years of comparable data are there for Belgium and Malaysia?
- 5 years are reported by both, from 2009 to 2020.
- How do Belgium and Malaysia rank globally for number of isolates tested for ceftriaxone?
- Belgium ranks 20th and Malaysia ranks 23rd of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.